Apellis Pharmaceuticals Funding: $93M Raised, Series E

Apellis Pharmaceuticals funding overview

Apellis Pharmaceuticals is based in Crestwood, KY. Apellis Pharmaceuticals has raised $93M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series E announced in August 2017. The round record for Apellis Pharmaceuticals runs through 2017; nothing later has been disclosed. Investors on record include Sectoral Asset Management, Sofinnova, Vivo Capital, F-Prime Capital Partners, Clough Capital Partners L.P., venBio Select and 5 others. 11 distinct backers are named across the disclosed rounds.

Apellis Pharmaceuticals at a glance

Total raised: $93M
Latest round: Series E
Latest round date: August 2017
Headquarters: Crestwood, KY
Notable investors: Sectoral Asset Management, Sofinnova, Vivo Capital, F-Prime Capital Partners, Clough Capital Partners L.P., venBio Select, Morningside Ventures, Cormorant Asset Management

Frequently asked about Apellis Pharmaceuticals funding

How much has Apellis Pharmaceuticals raised?: Apellis Pharmaceuticals has raised $93M in total disclosed funding across the rounds on record.
Who has invested in Apellis Pharmaceuticals?: Sectoral Asset Management, Sofinnova, Vivo Capital, F-Prime Capital Partners, Clough Capital Partners L.P., venBio Select are named among the investors backing Apellis Pharmaceuticals.
What was the latest Apellis Pharmaceuticals funding round?: The most recent disclosed round is a Series E, announced in August 2017.
Where is Apellis Pharmaceuticals based?: Apellis Pharmaceuticals is based in Crestwood, KY.
When did Apellis Pharmaceuticals last raise?: The last disclosed Apellis Pharmaceuticals round closed in August 2017 at Series E.

Every Apellis Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Crestwood at a similar stage.

Apellis Pharmaceuticals Funding: $93M Raised, Series E

Apellis Pharmaceuticals funding overview

Apellis Pharmaceuticals at a glance

Frequently asked about Apellis Pharmaceuticals funding

Companies related to Apellis Pharmaceuticals (13)

Browse related funding lists (6)